Jul. 27, 2022
MK-0159
oral CD38 inhibitor in vivo efficacy in a murine model of cardiac I/R from the previously disclosed inhibitor CD38i J. Med. Chem. Mitobridge (an Astellas Company), Cambridge, MA
oral CD38 inhibitor in vivo efficacy in a murine model of cardiac I/R from the previously disclosed inhibitor CD38i J. Med. Chem. Mitobridge (an Astellas Company), Cambridge, MA